Integrated spatial and multimodal single-cell transcriptomics reveal patient-dependent cell heterogeneity in splenic

Juan Pablo Cerapio1,2,3, Pauline Gravelle1,2,3,4,5, Anne Quillet-Mary1,2,3,4

  • 1Université de Toulouse, INSERM UMR1037, CNRS UMR5071, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

PubMed

Insights

This study reveals splenic marginal zone lymphoma (SMZL) cells exhibit desynchronized B-cell maturation between the spleen and blood. T-follicular helper cell interactions are key in the nodular SMZL subtype.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Biological hallmarks of splenic marginal zone lymphoma (SMZL) are not well understood.
  • Comprehensive characterization of SMZL requires advanced molecular profiling techniques.

Purpose of the Study:

  • To perform in-depth characterization of SMZL using multimodal single-cell analyses.
  • To elucidate the heterogeneity and biological mechanisms underlying SMZL.

Main Methods:

  • Integration of 3'-single-cell RNA-sequencing, Cellular Indexing of Transcriptomes and Epitopes by sequencing (CITE-seq), and 5'-V(D)J single-cell RNA-sequencing.
  • Spatial transcriptomics and imaging mass cytometry were employed for in situ analysis.

Main Results:

  • SMZL B-cell clones in the spleen are memory-like, while blood B-cells show diverse differentiation stages, indicating desynchronized maturation.
  • Nodular SMZL subtypes show enrichment of T-effector and T-follicular helper (TFH) signatures.
  • Evidence of dynamic crosstalk between TFH cells and cancer cells was observed.

Conclusions:

  • This study provides a high-resolution description of SMZL biological hallmarks.
  • First in situ characterization of inter- and intra-patient heterogeneity in SMZL at transcriptomic and protein levels.